Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Nat Cancer. 2020 Mar 23;1(4):382–393. doi: 10.1038/s43018-020-0047-1

Fig. 2. Safety and adverse events for the study.

Fig. 2.

a) Treatment associated adverse events for 51 patients included in the study. b) Presentation of maculopapular rash in the trunk. c) Skin histology demonstrating a superficial lympho-histiocytic infiltrate with eosinophils.